A subscription to JoVE is required to view this content. Sign in or start your free trial.
To analyze the function of lncRNAs in time-dependent processes such as chromosomal instability, a prolonged knockdown effect must be achieved. To that purpose, presented here is a protocol that uses modified antisense oligonucleotides to achieve effective knockdown in cell lines for 21 days.
Long noncoding RNAs (lncRNAs) play key regulatory roles in gene expression at the transcriptional level. Experimental evidence has established that a substantial fraction of lncRNA preferentially accumulates in the nucleus. For analysis of the function of nuclear lncRNAs, it is important to achieve efficient knockdown of these transcripts inside the nucleus. In contrast to the use of RNA interference, a technology that depends on the cytoplasmic silencing machinery, an antisense oligonucleotide (ASO) technology can achieve RNA knockdown by recruiting RNase H to the RNA-DNA duplexes for nuclear RNA cleavage. Unlike the use of CRISPR-Cas tools for genome engineering, where possible alterations in the chromatin state can occur, ASOs allow the efficient knockdown of nuclear transcripts without modifying the genome. Nevertheless, one of the major obstacles to ASO-mediated knockdown is its transitory effect. For the study of long-lasting effects of lncRNA silencing, maintaining efficient knockdown for a long time is needed. In this study, a protocol was developed to achieve a knockdown effect for over 21 days. The purpose was to evaluate the cis-regulatory effects of lncRNA knockdown on the adjacent coding gene RFC4, which is related to chromosomal instability, a condition that is observed only through time and cell aging. Two different human cell lines were used: PrEC, normal primary prostate epithelial cells, and HCT116, an epithelial cell line isolated from colorectal carcinoma, achieving successful knockdown in the assayed cell lines.
The vast majority of the human genome is transcribed, giving rise to a wide variety of transcripts, including lncRNAs, which, in number, exceed the number of annotated coding genes in the human transcriptome1. LncRNAs are transcripts longer than 200 nucleotides that do not encode proteins2,3 and have recently been examined for their important regulatory functions in the cell4. Their functions have been shown to be dependent on their subcellular localization5, such as the nucleus where a significant fraction of lncRNAs accumulate and a....
NOTE: This protocol is intended to be performed only by laboratory personnel with experience in laboratory safety procedures. It is essential to properly read the safety data sheets from all the reagents and materials used in this protocol prior to starting to handle hazardous materials and equipment. It is essential to read, understand and fulfill all the safety requirements indicated in your institution's laboratory safety manual along the whole protocol. Disposal of all biological and chemical waste must be perfor.......
In the present protocol, the use of ASOs was adapted to the KD of a nuclear lncRNA for a prolonged time in the human cell lines PrEC and HCT116.
Certainly, the KD experiment was successful in the cell line PrEC for 21 days of the experiment, as observed in Figure 4. To confirm this statement, in addition to analyzing expression in the days of cell passaging (Figure 4 A-C), we analyzed the checkpoints established betwe.......
As previously mentioned, lncRNAs have key regulatory functions in the cell; thus, dysregulation of these transcripts may be involved in diseases. Cancer is one such disease characterized by lncRNA dysregulation43,44. In this disease, lncRNAs are known to play important regulatory roles as oncogenes45 or tumor suppressors46. Some of them are involved in the development of hallmarks of cancer, and they can regulate, f.......
Montiel-Manriquez, Rogelio is a doctoral student from Programa de Doctorado en Ciencias Biomédicas, Universidad Nacional Autónoma de México (UNAM) and has received CONACyT fellowship with CONACyT CVU number: 581151.
....Name | Company | Catalog Number | Comments |
15ml Centrifuge Tubes - 15ml Conical Tubes | Thermo Fisher Scientific | 339650 | |
Corning 100 mm TC-treated Culture Dish | Corning | 430167 | Surface area:55 cm2 |
Corning 35 mm TC-treated Culture Dish | Corning | 430165 | Surface area: 9 cm2 |
DPBS, no calcium, no magnesium | Thermo Fisher Scientific | 14190144 | |
Fetal Bovine Serum (FBS) | ATCC | 30-2020 | |
HCT 116 cell line | ATCC | CCL-247 | |
HEPES, 1M Buffer Solution | Thermo Fisher Scientific | 15630122 | |
Integrated DNA Technologies | NA | NA | https://www.idtdna.com/ |
Lipofectamine RNAiMAX Reagent | Thermo Fisher Scientific | 13778150 | |
McCoy's 5A medium | ATCC | 30-2007 | |
Normal Human Primary Prostate Epithelial Cells (HPrEC) | ATCC | PCS-440-010 | |
Nucleotide Blast NCBI | NA | NA | https://blast.ncbi.nlm.nih.gov/Blast.cgi |
Opti-MEM Reduced Serum Media | Thermo Fisher Scientific | 31985070 | |
PBS (10X), pH 7.4 | Thermo Fisher Scientific | ||
Prostate Epithelial Cell Basal Medium | ATCC | PCS-440-030 | |
Prostate Epithelial Cell Growth Kit | ATCC | PCS-440-040 | |
Reverse complement online tool | NA | NA | https://www.bioinformatics.org/sms/rev_comp.html |
RNAfold WebServer | NA | NA | http://rna.tbi.univie.ac.at//cgi-bin/RNAWebSuite/RNAfold.cgi |
RNase-free Microfuge Tubes, 1.5 mL | Thermo Fisher Scientific | AM12400 | |
TrypLE Express Enzyme (1X), no phenol red | Thermo Fisher Scientific | 12604013 | Trypsin-EDTA solution |
Trypsin Neutralizing Solution | ATCC | PCS-999-004 | |
Trypsin-EDTA for Primary Cells | ATCC | PCS-999-003 | |
UCSC Genome Browser, Human (GRCh38/hg38) | NA | NA | https://genome.ucsc.edu/ |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved